Tracy Mcgregor
Tracy McGregor, Alnylam Pharmaceuticals, Cambridge, MA, United States
Biography
Dr. Tracy McGregor joined Alnylam Pharmaceuticals as Director of Clinical Research in 2016 where she serves as the medical lead for the lumasiran (formerly ALN-GO1) program, an investigational RNAi therapeutic for the potential treatment of Primary Hyperoxaluria, Type 1. Previously, she was Vanderbilt University Medical Center as a Clinical Geneticist at. She trained in Pediatrics and Clinical Genetics at St. Louis Children’s Hospital, and holds board certification in both. Dr. McGregor obtained her medical degree at Washington University in St. Louis and her Master of Science in Clinical Investigation at Vanderbilt.
Abstract
Abstract : A Phase 1/2 Trial of Lumasiran, an Investigational RNAi Therapeutic for Primary Hyperoxaluria Type 1